Page last updated: 2024-10-22

amitriptyline and Abnormality, Heart

amitriptyline has been researched along with Abnormality, Heart in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radnic, B1
Radojevic, N1
Vucinic, J1
Duborija-Kovacevic, N1
Schwingshackl, H1
Amor, H1
Wilflingseder, S1
Dienstl, F1
Druml, W1
Friedl, R1

Other Studies

2 other studies available for amitriptyline and Abnormality, Heart

ArticleYear
The association between pro-arrhythmic agents and aortic stenosis in young adults: is it sufficient to clarify the sudden unexpected deaths?
    Cardiology in the young, 2017, Volume: 27, Issue:5

    Topics: Adult; Amitriptyline; Aortic Valve Stenosis; Arrhythmias, Cardiac; Autopsy; Caffeine; Death, Sudden,

2017
[Haemodynamic effects of amitriptyline (Laroxyl) (author's transl)].
    Wiener klinische Wochenschrift, 1974, Sep-06, Volume: 86, Issue:16

    Topics: Adolescent; Adult; Aged; Amitriptyline; Aorta; Blood Pressure; Cardiac Catheterization; Depression;

1974